Eurohealth: commercial determinants of cancer control policy
27 April 2022
| Journal article

Overview
This Eurohealth special issue seeks to understand the commercial determinants of cancer control policy. This relates to private-sector activities that affect the health of populations. The articles present the dimensions of the commercial determinants and how to govern them along the cancer continuum - from prevention and screening, through integrated treatment and palliative care - to provide a potentially useful descriptive and analytical basis for governments and the international community.
WHO Team
EURO Europe Regional Office (RGO),
NCD Management CHP (NCD)
Reference numbers
WHO Reference Number: 1356-1030